| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Chenodeoxycholate in females with irritable bowel syndrome-constipation: a pharmacodynamic and pharmacogenetic analysis. | Gastroenterology | 2010 | 1.53 |
| 2 | Urine sugars for in vivo gut permeability: validation and comparisons in irritable bowel syndrome-diarrhea and controls. | Am J Physiol Gastrointest Liver Physiol | 2011 | 1.38 |
| 3 | Effect of daikenchuto (TU-100) on gastrointestinal and colonic transit in humans. | Am J Physiol Gastrointest Liver Physiol | 2010 | 1.32 |
| 4 | New-generation 5-HT4 receptor agonists: potential for treatment of gastrointestinal motility disorders. | Expert Opin Investig Drugs | 2010 | 0.93 |
| 5 | Effect of a glucagon-like peptide 1 analog, ROSE-010, on GI motor functions in female patients with constipation-predominant irritable bowel syndrome. | Am J Physiol Gastrointest Liver Physiol | 2012 | 0.83 |
| 6 | Emerging pharmacologic therapies for irritable bowel syndrome. | Curr Gastroenterol Rep | 2010 | 0.81 |